🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/09/1993 | 14,97 | 15,03 | 14,55 | 14,55 | -2,79% | 3,19% | 4.900.029 |
| 17/09/1993 | 14,91 | 15,15 | 14,91 | 14,97 | -1,18% | 1,60% | 9.853.296 |
| 16/09/1993 | 15,33 | 15,33 | 14,97 | 15,15 | -0,78% | 2,33% | 3.316.710 |
| 15/09/1993 | 15,21 | 15,33 | 15,03 | 15,27 | -0,39% | 1,96% | 6.038.786 |
| 14/09/1993 | 14,97 | 15,33 | 14,97 | 15,33 | +2,39% | 2,39% | 6.165.594 |
| 13/09/1993 | 15,15 | 15,21 | 14,91 | 14,97 | -1,57% | 1,97% | 4.356.117 |
| 10/09/1993 | 15,27 | 15,27 | 15,15 | 15,21 | -0,39% | 0,78% | 3.396.149 |
| 09/09/1993 | 15,15 | 15,39 | 15,09 | 15,27 | +0,79% | 1,97% | 3.706.566 |
| 08/09/1993 | 15,27 | 15,27 | 14,91 | 15,15 | -1,55% | 2,34% | 5.343.542 |
| 07/09/1993 | 15,74 | 15,80 | 15,27 | 15,39 | -1,90% | 3,41% | 4.542.661 |
| 03/09/1993 | 15,80 | 15,80 | 15,57 | 15,68 | -0,75% | 1,51% | 7.206.467 |
| 02/09/1993 | 15,45 | 15,86 | 15,45 | 15,80 | +3,92% | 2,70% | 13.454.224 |
| 01/09/1993 | 15,21 | 15,27 | 15,09 | 15,21 | +0,00% | 1,18% | 5.568.024 |
| 31/08/1993 | 15,21 | 15,39 | 15,09 | 15,21 | +0,00% | 1,96% | 7.185.926 |
| 30/08/1993 | 15,68 | 15,68 | 15,15 | 15,21 | -3,04% | 3,42% | 5.482.507 |
| 27/08/1993 | 15,57 | 15,68 | 15,51 | 15,68 | +0,77% | 1,15% | 3.752.469 |
| 26/08/1993 | 15,21 | 15,74 | 15,09 | 15,57 | +2,76% | 4,31% | 6.221.138 |
| 25/08/1993 | 15,45 | 15,45 | 15,15 | 15,15 | -1,55% | 1,93% | 5.546.645 |
| 24/08/1993 | 15,45 | 15,51 | 15,33 | 15,39 | -0,77% | 1,16% | 5.124.720 |
| 23/08/1993 | 15,57 | 15,63 | 15,21 | 15,51 | -0,76% | 2,68% | 6.165.174 |
| 20/08/1993 | 15,80 | 15,86 | 15,39 | 15,63 | -1,13% | 3,02% | 8.786.013 |
| 19/08/1993 | 15,68 | 16,10 | 15,63 | 15,80 | +1,92% | 3,04% | 15.828.992 |
| 18/08/1993 | 15,15 | 15,57 | 15,09 | 15,51 | +5,26% | 3,15% | 18.441.656 |
| 17/08/1993 | 14,19 | 14,79 | 14,13 | 14,73 | +4,66% | 4,62% | 10.293.666 |
| 16/08/1993 | 13,72 | 14,07 | 13,66 | 14,07 | +2,61% | 3,04% | 6.867.544 |
| 13/08/1993 | 13,72 | 13,96 | 13,66 | 13,72 | -0,43% | 2,17% | 7.565.302 |
| 12/08/1993 | 14,07 | 14,13 | 13,78 | 13,78 | -2,53% | 2,54% | 8.404.541 |
| 11/08/1993 | 14,37 | 14,37 | 13,96 | 14,13 | -1,25% | 2,90% | 9.008.189 |
| 10/08/1993 | 14,55 | 14,61 | 14,31 | 14,31 | -2,04% | 2,05% | 7.389.658 |
| 09/08/1993 | 14,67 | 14,73 | 14,55 | 14,61 | -0,41% | 1,22% | 5.726.062 |